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Abstract The surfactant-associated polypeptide C (SP-C) is a 
35-residue lipopolypeptide which is essential for the function of 
surfactants used for therapy of infant respiratory distress. Mod- 
eling based on the recently determined nuclear magnetic reso- 
nance (NMR) structure of native SP-C in an organic solvent 
showed that SP-C could readily insert into fluid 1,2-dipalmitoyl- 
sn-glycero-3-phosphocholine bilayers. The present paper de- 
scribes further physical-chemical studies of intact SP-C and its 
N-terminal 17-residue polypeptide fragment, depalmitoyl-SP- 
C(1-17), in the presence of dodecylphosphocholine micelles. The 
results obtained provide a link between the NMR solution struc- 
ture and the behaviour of SP-C in an ordered lipid environment, 
and thus present new insights for rational design of SP-C analogs 
for therapeutic purposes. 
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I. Introduction 
Pulmonary surfactant isa complex mixture of phospholipids, 
primarily 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC),
and at least three surfactant-associated polypeptides, SP-A, 
SP-B and SP-C, of which SP-B and SP-C are pronouncedly 
hydrophobic. The main function of pulmonary surfactant is to 
reduce the surface tension at the alveolar air/liquid interface, 
thereby preventing alveolar collapse at the end of expiration 
(for reviews ee [1,2]). Lack of sufficient amounts of surfactant 
in premature infants is associated with respiratory distress yn- 
drome (RDS), which is a major cause of neonatal morbidity 
and mortality. RDS can be effectively treated by airway instil- 
lation of exogenous surfactant preparations. Essential compo- 
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nents of such preparations are phospholipids, especially DPPC, 
and small amounts of SP-B and SP-C [3,4]. 
Endogenous pulmonary surfactant is synthesized in alveolar 
type II cells and stored intra-cellularly in dense multibilayer 
structures. These 'lamellar bodies' are excreted into the alveolar 
liquid subphase, where they are converted into more complex 
bilayer structures ('tubular myelin'), from which the surface- 
active monolayers are eventually formed. SP-C is thought o 
have an important role in facilitating the conversion of sub- 
phase bilayer structures into surface-active DPPC monolayers 
at the air/liquid interface [5-10]. Since large-scale production 
of natural SP-B and SP-C is difficult, the development of syn- 
thetic, possibly non-peptide analogs for therapeutic purposes 
is of great potential interest [11,12]. 
The surfactant polypeptide-C (SP-C) is a highly hydropho- 
bic, small protein (Fig. 1), which is difficult not only to prepare 
in adequate amounts, but also to handle at all stages of an 
experimental investigation. Recently, we succeeded nonetheless 
in obtaining a high-quality nuclear magnetic resonance (NMR) 
structure in a mixed organic solvent [13]. This SP-C structure 
contains a highly regular ~z-helix from residues 9 34, whereas 
the N-terminal octapeptide segment, as well as the C-terminal 
dipeptide segment are flexibly disordered (Fig. 1). In order to 
obtain a better foundation for evaluating the physiological sig- 
nificance of the NMR structure in acid chloroform/methanol 
[13], we now present circular dichroism (CD) and NMR studies 
of SP-C and of its N-terminal heptadecapeptide, palmitoyl- 
SP-C(1-17), in dodecylphosphocholine (DPC) micelles, which 
mimic more closely the physiological conditions under which 
the surfactant acts in vivo. Based on the combination of the 
previously described NMR structure of SP-C [13] with these 
new experimental measurements, we propose a possible mode 
of interaction of SP-C with natural ipid bilayers that should 
help in the future design of artificial compounds with functional 
properties akin to those of surfactant-associated polypeptides, 
which they could then possibly replace in exogenous surfactant 
preparations. 
**Present address: Department of Medical Biochemistry and 
Biophysics, Karolinska Institutet, S-171 77 Stockholm, Sweden. 2. Materials and methods 
Abbreviations: SP-C, surfactant-associated polypeptide C; depalmitoyl- 
SP-C(1-17), N-terminal heptadecapeptide fragment of SP-C; DPC, do- 
decylphosphocholine; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phospho- 
choline; TSP, [2,2,3,3-2H4]-trimethylsilyl-propionate; RDS, respiratory 
distress yndrome; CD, circular dichroism; NMR, nuclear magnetic 
resonance; ppm, parts per million; 2QF-COSY, two-dimensional two- 
quantum filtered correlation spectroscopy; TOCSY, two-dimensional 
total correlation spectroscopy; NOE, nuclear Overhauser enhance- 
ment; NOESY, two-dimensional nuclear Overhauser enhancement 
spectroscopy. 
2.1. Sample preparation 
Depalmitoyl-SP-C(1 7), with the sequence LRIPCCPVNLKRLL- 
VVV (see also Figs. 1 and 3), was prepared by chemical synthesis using 
the tert-butyloxycarbonyl method. The peptide was liberated by treat- 
ment with hydrogen fluoride, and the protection groups were removed 
by diethylether xtraction. Depalmitoyl-SP-C(1-17) was recovered by 
extraction with 30% (v/v) acetic acid in H20, lyophilized and purified 
by reverse-phase high-performance liquid chromatography (Vydac 
C18, 3 × 25 em, flow 10 ml/min, linear gradient of acetonitrile/0.1% 
trifluoroacetic acid). Sequence, purity and monomeric state were veri- 
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fled by amino acid analysis, sequence analysis and mass spectrometry. 
The micelle-bound form of depalmitoyl-SP-C(1-17) was prepared fol- 
lowing established procedures [14], using perdeuterated o- 
decylphosphocholine ([2H38]DPC) at concentrations above the critical 
micelle concentration of 1 mM [15] where micelles of defined size but 
no bilayer structures are formed. 3.2 mg ofdepalmitoyl-SP-C(1-17) and 
42.0 mg of [2H38]DPC were mixed in chloroform/methanol 1 : 2 (v/v). 
The mixture was sonicated, dried under a stream of nitrogen, and then 
dissolved in 500pl of 50 mM sodium phosphate at pH 3.6 in H20/2HzO, 
9:1. The final concentrations of depalmitoyl-SP-C(1-17) and 
[2H38]DPC were 3.3 mM and 0.2 M, respectively, which corresponds 
approximately to a 1:1 molar ratio between peptide and micelles 
[14,16,17]. A solution in 2H20 was prepared by twice lyophilizing this 
sample from 2H20, and redissolving it in 99.96% 2H20. 
2.2. NMR experiments 
All NMR spectra were recorded at 34°C on Bruker AMX 500 and 
AMX 600 spectrometers operating at tH frequencies of 500 MHz and 
600 MHz, respectively. Quadrature detection i  the indirectly detected 
dimension was obtained using the States-TPPI method [18]. The spectra 
were processed on a Bruker X32 workstation using the program 
UXNMR. The residual water signal after preirradiation during the 
relaxation delay was further educed with the convolution method of 
Marion et al. [19]. Before Fourier transformation the time domain data 
were zero-filled and multiplied with shifted sine-bell windows [20]. The 
spectra were baseline-corrected using third order polynomials. Stand- 
ard procedures were used to obtain the 1H resonance assignments: 
2QF-COSY [21] (data size 512 × 1024 complex points, q,,~x = 102 ms, 
t2m,.~ = 205 ms, digital resolution 4.9 Hz in o9~ and 2.4 Hz in co2) and 
clean-TOCSY [22] (mixing time = 80 ms, data size 400 x 1024 complex 
points, fimax = 84 ms, t2m,x = 205 ms, digital resolution 4.7 Hz in o91 and 
2.4 Hz in ¢o2) spectra were recorded at 500 MHz. For the identification 
of NOEs and the determination f 3Jun ~ scalar coupling constants [23] 
(Fig. 3), a NOESY spectrum [24] (mixing time = 100 ms, data size 
384 x 1536 complex points, t~,~ x = 67 ms, t2 .... = 267 ms, digital resolu- 
tion 5.6 Hz in o91 and 1.4 Hz in o92) and a soft-NOESY spectrum [25] 
(mixing time = 100 ms, data size 512 x 1024 complex points, tlmax ---- 80 
ms, t2~ax = 160 ms, digital resolution 6.3 Hz in o9~ and 3.1 Hz in o92) were 
recorded at 600 MHz. Amide proton exchange rates (Fig. 3) were 
determined by dissolving the lyophilized depalmitoyl-SP-C(1-17)/ 
[ZH38]DPC mixture in 2H20 and monitoring the time course of the 
amide proton signals at 34°C in a series of one-dimensional IH NMR 
spectra t 500 MHz. 
3.  Resu l t s  
DPC-micelles [14,16] solubilize native SP-C, and CD meas- 
H3C CH 3 
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I I 
o=c  c=o 
I I 10  
urements (Fig. 2) indicate that the polypeptide is 80-90% helical 
in this environment. However, in contrast o other membrane- 
active polypeptides of similar size, for which NMR structure 
determinations in DPC micelles were achieved [17,26,27], exces- 
sive line broadening for micelle-bound SP-C prevented a deter- 
mination of the NMR structure. This was true also for the 
full-length SP-C polypeptide lacking the thioester-linked palmi- 
toyl side chains (Fig. 1), indicating that the observed NMR line 
broadening cannot be accounted for by possible cross-linking 
of micelles via the palmitoylcysteinyls. 
Unlike full-length SP-C, the micelle-bound form of the syn- 
thetic polypeptide comprising the amino acid residues 1-17 of 
porcine SP-C, depalmitoyl-SP-C(1-17), was amenable to sec- 
ondary structure determination by NMR.  Using standard pro- 
cedures [28,29], nearly complete sequence-specific ~H NMR 
assignments were obtained (Table 1; Fig. 3). Sequential nuclear 
Overhauser enhancement (NOE) connectivities are missing for 
Cys6-Pro 7 and Leul3-Leu 14 (Fig. 3), because the Cys 6 s-proton 
resonance is masked by the residual water signal and the chem- 
ical shifts of Leu 13 and Leu 14 are nearly degenerate (Table 
1). The otherwise consecutive strong dNN connectivities from 
positions 10-17 and the medium-range NOEs observed in this 
polypeptide segment (Fig. 3) indicate a helical conformation for 
this octapeptide segment [28-30]. This is further supported by 
small values of the 3JNH ~ spin-spin coupling constants [31] and 
slowed amide proton exchange rates for residues 13-17 (Fig. 
3). After correction for primary structure ffects [32] (but not 
for possible shielding by the micellar environment), the ex- 
change rate constants for residues 14-16 reflect a protection 
factor of about 10. The NMR data for residues 1-9 ofdepalmi- 
toyl-SP-C(1-17) (Fig. 3) are compatible with a flexibly disor- 
dered conformation of this polypeptide segment [29]. The CD 
spectrum or depalmitoyl-SP-C(1-17) in DPC micelles (Fig. 2) 
indicates a helix content of approximately 40%, which coincides 
well with the extent of helical structure observed by NMR (Fig. 
3). Fig. 4A shows a hypothetical arrangement of depalmitoyl- 
SP-C(1-17) relative to the DPC micelle to which it is bound, 
which would provide a rationale for the observed conformation 
of the polypeptide (Fig. 3). 
Overall, there are thus several lines of evidence that the 
20 30  
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Fig. 1. The upper part shows the primary structure of the porcine lipopolypeptide SP-C [44], with the palmitoylcysteinyl residues in positions 5 and 
6 [45]. The lower part shows the NMR solution structure in a mixed solvent of CDCI3/CD3OH/0.1 M HC1 32:64:5 (v/v) at 10°C [13] represented 
by a superposition of 20 conformers [29] for optimal fit of the backbone heavy atoms of residues 9-34, where the positions of the C a atoms of Asn 9 
and Gly 34 align with the corresponding one-letter code in the amino acid sequence. 
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Fig. 2. CD spectra between 184 and 250 nm of native SP-C and depalmi- 
toyl-SP-C(l-17) in 10 mM DPC/50 mM sodium phosphate atpH 6.0. 
The peptides were solubilized in 150/tl of 20 mM DPC/50 mM sodium 
phosphate at pH 6.0, and the solution was then diluted with buffer to 
I0 mM DPC. The CD spectra were recorded with a Jasco J-720 spectro- 
polarimeter at 22°C (scan speed 20 nrn/min, one scan per spectrum 
acquired, concentration fnative SP-C -- 30 pM and of depalmitoyl- 
SP-C(1-17) = 60/IM, as determined by amino acid analysis). O is in 
units of 104 deg.cm2.mo1-1. 
s-helical structure of natural SP-C determined in an organic 
solvent mixture (Fig. 1) is preserved in phospholipid environ- 
ments similar to pulmonary surfactant. From our work this 
includes the CD data of Fig. 2, which indicate a high helix 
content for SP-C in DPC micelles, and the NMR data of Fig. 
3, which show that the onset of helical structure in micelle- 
bound depalmitoyl-SP-C(1-17) is at a nearly identical sequence 
location as in native SP-C in solution (Fig. 1). In work by 
others, Fourier transform infrared spectroscopy ofnative SP-C 
in phospholipid bilayers with compositions similar to that of 
pulmonary surfactant phospholipids showed that the polypep- 
tide is between 60% and 90% s-helical, and that the axis of the 
SP-C helix is oriented perpendicular to the membrane surface 
[33,34]. Taken together, these data show that the conformation 
of SP-C is not significantly affected by the nature of the apolar 
environment and that, therefore, the or-helical structure deter- 
mined for native SP-C in an organic solvent (Fig. 1) is also 
preserved in a phospholipid environment. Similar conclusions 
resulted from work on isolated transmembrane h lices from 
bacteriorhodopsin, for which similar structures have been ob- 
served in organic solvents, detergent micelles and in the intact 
protein [35]. 
4. Discussion 
The length of the entire helix from residues 9-34 of SP-C 
(Fig. 1) and that of its pronouncedly hydrophobic part from 
residues 13-28 are about 37 and 23 A,, respectively, which is 
remarkably close to the experimentally determined overall 
thickness of a DPPC phospholipid bilayer (37 A) and its inte- 
rior acyl-chain part (26 A) in the liquid-crystalline phase [36]. 
Thus, in a transmembrane orientation of SP-C in surfactant 
phospholipids, the rigid hydrophobic helix of residues 13-28 
would span the hydrocarbon part of the bilayer (Fig. 4B). This 
close match of the length of native SP-C with the thickness of 
a fluid DPPC bilayer and the lesser fit with the larger thickness 
of 39 A for the all-hydrophobic part of the same bilayer in the 
gel phase [37] could be of importance for SP-C function, since 
mismatches between the length of a transmembrane p ptide 
and the bilayer thickness are known to cause phase separation 
of peptides and lipids, especially when the peptide is shorter 
than the bilayer [37]. Consequently, from the size of the SP-C 
~z-helix one would expect hat the polypeptide is more favoura- 
bly accommodated in fluid DPPC bilayers than in gel phase 
DPPC. This affords a molecular explanation of the recent find- 
ing that SP-C is predominantly monomeric in fluid DPPC/ 
dipalmitoylphosphatidylglycerol (DPPG) vesicles, but under- 
goes self-aggregation in the same lipid mixture below the tran- 
sition temperature between gel phase and liquid-crystalline 
phase [38]. Accordingly, the decrease of the phase transition 
temperature of phospholipid vesicles caused by SP-C [10] may 
be due to peptide aggregates disrupting the lipid packing in the 
gel phase. 
One observes further that in the trans-membrane orientation 
of Fig. 4B, the evolutionarily strictly conserved Lys-Arg dipep- 
tide segment in positions 11-12 [39] is suitably located for 
interacting with the phosphatidyl choline moieties of DPPC. 
This would also be in agreement with deuterium NMR studies 
of selectively deuterated DPPC preparations containing varia- 
ble amounts of SP-C, which provided evidence for direct inter- 
actions between the positive charges of SP-C and the lipid 
headgroups [40]. Furthermore, the palmitoylcysteinyls at posi- 
tions 5 and 6 are then located near the exterior surface of the 
DPPC bilayer (Fig. 4B). The exact location of the palmitoyl 
chains is unknown, but closer inspection of the situation offers 
only two alternatives: the lipid chains can either fold back and 
interact with the same bilayer that contains the polypeptide 
chain to which they are attached, or they can interact with a 
Table 1 
~H chemical shifts of 3.3 mM depalmitoyl-SP-C(1-17) in 0.2 M 
[2H38]DPC/50 mM sodium phosphate at pH 3.6 and 34°C 
Residue Chemical shift (ppm)* 
NH ~H flH Others 
Leu j 3.99 1.70 
Arg 2 8.61 4.47 1.72, 
Ile 3 8.30 4.37 1.88 
1.79 
Pro 4 4.48 1.98, 2.31 
Cys 5 8.03 4.41 2.88 
Cys 6 8.70 4.66 2.72, 2.99 
Pro 7 4.54 2.06, 2.36 
Val 8 7.97 4.08 2.05 
Asn 9 8.63 4.69 2.82, 2.89 
Leu I° 8.16 4.08 1.66 
Lys 11 8.06 3.86 1.88 
Arg 12 7.71 4.09 1.82, 
Leu 13 7.65 4.09 1.65, 
Leu 14 7.59 4.08 1.63, 
Va115 7.25 4.04 2.27 
Val ~6 7.39 4.18 2.28 
Va117 7.32 4.17 2.22 
1.88 
1.81 
1.80 
xCH 1.64; 8CH3 0.92, 0.94 
xCH2 1.51, 1.57; 8CH 2 3.17; 
eNH 7.33 
TCH 2 1.17, 1.56; xCH3 0.98; 
~CH 3 0.86 
7CH2 2.17; ~CH2 3.53, 3.94 
?'CH2 1.99; ~CH2 3.76, 3.99 
7CH3 0.92 
6NH2 6.90, 7.81 
~CH 3 0.84, 0.92 
xCH 2 1.43, 1.53; ~CH 2 1.72; 
eCH2 2.94; ~H~ 7.69 
xCHz 1.71; 6CH 2 3.18, 3.23; 
eNH 7.42 
~CH 3 0.83, 0.91 
8CH3 0.84, 0.92 
~'CH3 0.98, 1.04 
~'CH3 0.97, 1.02 
xCH3 0.97 
*The chemical shifts are in ppm relative to TSP. For methylene and 
isopropyl groups two chemical shifts are given only when two separate 
lines could be identified. Atom groups for which no resonance lines 
could be identified are not listed. 
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Fig. 3. Survey of experimental NMR data for depalmitoyl-SP-C(1-17) 
bound to [2H38]DPC micelles. In the row kNn, filled and open squares 
identify, respectively, the residues with amide proton exchange rate 
constants kNn < 1.0" 10 -2 min -1, and 1.0.10 -2 min -1 < kN~ < 1.0.10 -l
min -I at p2H 3.6 and 34°C. In the row 3JNn~, filled and open circles 
denote the residues with 3JNH= < 6.0 Hz, and 6.0 Hz < 3JNH ~ < 8.0 Hz, 
respectively. The sequential NOE connectivities duN, d~N and dpN are 
presented by horizontal bars, where the thickness of the bars reflects 
the intensities of the NOEs. The medium-range NOEs dNu(i,i + 2), 
d~N(i,i+ 3), d~(i,i+ 3) and d~N(i,i+2 ) are represented by lines 
starting and ending at the positions of the residues connected. At the 
bottom the location of c~-helical structure determined by the NMR data 
is indicated. 
that the principal influence of SP-C on phospholipid adsorption 
rates should occur rather by destabilization of bilayer struc- 
tures in the alveolar liquid subphase than by direct interactions 
with the monolayer structures. This would also be in agreement 
with a recent study [41] which suggests that SP-C may act by 
enhancing the respreading of collapsed DPPC structures that 
have been squeezed out of the compressed monolayer to the 
interphase during expansion of the alveolar surface. Our con- 
clusion may also be correlated with the fact that in a model 
system, SP-C installed in a monolayer is less effective than SP-B 
in accelerating adsorption of phospholipids from the alveolar 
subphase [8]. Furthermore, in the same model system the pres- 
ence or absence of the palmitoyl groups in positions 5 and 6 
11 
second, neighbouring bilayer. The possible ffects of such inter- 
actions on the structure and dynamics of the N-terminal oc- 
tapeptide segment cannot be evaluated from the present struc- 
tural data, which were obtained either in an organic solvent in 
the absence oflipids (Fig. 1, [13]) or using depalmitoyl-SP-C(1- 
17) (Fig. 3). The palmitoylcysteinyls and the basic residues 11 
and 12 are both located in the N-terminal half of SP-C, while 
the C-terminal half of the sequence contains exclusively resi- 
dues with non-polar side chains (Fig. 1). The N-terminal dode- 
capeptide segment with the basic residues and the palmitoyl 
'side chains' is thus likely to anchor the SP-C molecules on one 
side of the DPPC bilayer in the sense that lateral movements 
of the lipopolypeptide are restricted, while the C-terminal part 
contains no groups that would tend to interact specifically with 
the head groups. It is tempting to speculate that the herewith 
implicated mobility gradient across the lipid bilayer is linked to 
the observed capacity of SP-C to accelerate the transformation 
of lipid bilayers to lipid mono-layers, and it correlates with the 
finding that addition of SP-C increases the ordering of the 
bilayer surface but tends to disrupt the interior acyl chain 
packing [7]. 
In contrast o the near-perfect fit with the dimensions of a 
fluid DPPC bilayer, the solution structure of SP-C (Fig. 4B) 
could hardly be stably incorporated into the surface-active 
DPPC monolayer at the air/liquid interface, since the width of 
such monolayers corresponds to only about half of the length 
of the helical part of SP-C in the conformation of Fig. 1, and 
the poly-valyl s-helix is an outstandingly rigid structure that 
could not readily kink or even fold back on itself. This implies 
B 
L35 
Fig. 4. Schematic representations f depalmitoyl-SP-C(1-17) and SP-C 
in lipid environments (see text). (A) Depalmitoyl-SP-C(1-17) in DPC 
micelles. The locations of the N-terminal residue and the positively 
charged residues 11 and 12 are indicated. (B) Native SP-C in a DPPC 
bilayer, assuming that the s-helical conformation observed in an or- 
ganic solvent [13] is preserved in this environment. The N-terminus, the 
palmitoylcysteinyl residues in positions 5and 6, the positively charged 
residues in positions 11 and 12, and the C-terminus are indicated. In 
both drawings, which were prepared using the program MOLSCRIPT 
[46], the shaded ovals and the wavy lines represent, respectively, the 
polar head groups and the fatty acyl chains of the lipid molecules. 
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(Fig. l) apparently does not correlate with the ability of the 
peptide to induce phospholipid insertion into the monolayer 
[42]. Due to the fundamental differences between the mono- 
layer model system and the trans-bilayer orientation of SP-C 
now deduced from the structure determination i  solution [13] 
(Fig. 4B), further work is needed to investigate the functional 
implications of the palmitoyl groups when SP-C interacts with 
the phospholipid bilayers. 
The indications from the present study on structure-function 
correlations of SP-C should provide a lead for rational design 
of SP-C analogs with grossly preserved molecular parameters 
and hopefully also functional properties, but with covalent 
structures that would make them easier to synthesize and purify 
than the natural product. In addition to the biomedical interest, 
further studies of the SP-C system also bear on questions of 
stability and functionality of biologically active polypeptide 
conformations. It remains to be seen whether formation of a 
long a-helical stretch by residues with fl-branched aliphatic side 
chains (Fig. 1), which has previously also been reported for 
model peptides with poly-valyl blocks [43], is simply an extreme 
adaptation to a hydrophobic environment, or is more specifi- 
cally related with biological function. Further investigations of
structure and function of SP-C analogs might also shed some 
light on this fundamental question. 
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